GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSeed Inc (TSE:7776) » Definitions » Cyclically Adjusted PB Ratio

CellSeed (TSE:7776) Cyclically Adjusted PB Ratio : 3.96 (As of May. 25, 2025)


View and export this data going back to 2010. Start your Free Trial

What is CellSeed Cyclically Adjusted PB Ratio?

As of today (2025-05-25), CellSeed's current share price is 円540.00. CellSeed's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was 円136.53. CellSeed's Cyclically Adjusted PB Ratio for today is 3.96.

The historical rank and industry rank for CellSeed's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:7776' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.81   Med: 1.7   Max: 6.22
Current: 3.96

During the past years, CellSeed's highest Cyclically Adjusted PB Ratio was 6.22. The lowest was 0.81. And the median was 1.70.

TSE:7776's Cyclically Adjusted PB Ratio is ranked worse than
74.55% of 668 companies
in the Biotechnology industry
Industry Median: 1.485 vs TSE:7776: 3.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CellSeed's adjusted book value per share data for the three months ended in Dec. 2024 was 円62.401. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円136.53 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CellSeed Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CellSeed's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSeed Cyclically Adjusted PB Ratio Chart

CellSeed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 1.18 1.02 1.73 2.92

CellSeed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 1.73 1.49 2.51 2.92

Competitive Comparison of CellSeed's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, CellSeed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSeed's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSeed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CellSeed's Cyclically Adjusted PB Ratio falls into.


;
;

CellSeed Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CellSeed's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=540.00/136.53
=3.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSeed's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, CellSeed's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=62.401/110.7000*110.7000
=62.401

Current CPI (Dec. 2024) = 110.7000.

CellSeed Quarterly Data

Book Value per Share CPI Adj_Book
201412 324.816 97.900 367.284
201503 297.715 97.900 336.640
201506 287.014 98.400 322.891
201509 270.729 98.500 304.261
201512 268.992 98.100 303.541
201603 246.642 97.900 278.889
201606 228.236 98.100 257.551
201609 201.466 98.000 227.574
201612 126.378 98.400 142.175
201703 124.337 98.100 140.307
201706 131.325 98.500 147.591
201709 124.116 98.800 139.065
201712 110.169 99.400 122.693
201803 100.038 99.200 111.635
201806 106.426 99.200 118.764
201809 102.170 99.900 113.215
201812 123.203 99.700 136.796
201903 109.623 99.700 121.718
201906 94.982 99.800 105.356
201909 89.727 100.100 99.229
201912 103.666 100.500 114.187
202003 100.295 100.300 110.694
202006 104.293 99.900 115.568
202009 91.692 99.900 101.605
202012 95.351 99.300 106.298
202103 85.352 99.900 94.579
202106 80.092 99.500 89.107
202109 69.966 100.100 77.375
202112 58.822 100.100 65.051
202203 51.207 101.100 56.069
202206 58.647 101.800 63.774
202209 48.811 103.100 52.409
202212 48.249 104.100 51.308
202303 58.927 104.400 62.483
202306 59.271 105.200 62.370
202309 72.871 106.200 75.959
202312 68.811 106.800 71.324
202403 64.750 107.200 66.864
202406 63.295 108.200 64.757
202412 62.401 110.700 62.401

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CellSeed  (TSE:7776) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CellSeed Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CellSeed's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSeed Business Description

Industry
Traded in Other Exchanges
N/A
Address
Katsura-Bldg, 4F, 3-61, Haramachi, Shinjuku-ku, Tokyo, 162-0053, JPN
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

CellSeed Headlines

No Headlines